<DOC>
	<DOCNO>NCT01196754</DOCNO>
	<brief_summary>This prospective clinical monocentric study ICU sedate ventilated patient sevoflurane 48 h AnaConda® system , establish pharmacokinetic model sevoflurane .</brief_summary>
	<brief_title>Pharmacokinetic Sevoflurane During 48h Sedation Intensive Care Unit With AnaConDa®</brief_title>
	<detailed_description>Prospective clinical monocentric study ICU sedate ventilated patient sevoflurane 48 h AnaConda® system , establish pharmacokinetic model sévoflurane metabolite ( hydroxyfluroisopropanol , fluoride )</detailed_description>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Adult patient ventilate 48 h Stable respiratory hemodynamic condition Consent patient family Arterial line Acute kidney injury Obesity Sevoflurane anaphylaxia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Fluorides</keyword>
	<keyword>Sedation</keyword>
	<keyword>Adult patient predict sedation 48 h</keyword>
	<keyword>Stable respiratory hemodynamic condition SBT</keyword>
	<keyword>Consent patient</keyword>
	<keyword>Arterial line</keyword>
</DOC>